Improved clinical and simplified disease activity index (CDAI, SDAI) scores with rituximab in patients with rheumatoid arthritis (RA) and an inadequate response to TNF inhibitors

被引:0
|
作者
Smolen, Josef [1 ]
Cividino, Alfred [2 ]
Kavanugh, Arthur [3 ]
Tony, Hans Peter [4 ]
Greenwald, Maria
De Vita, Salvatore [5 ]
Brasington, Richard [6 ]
Aletaha, Daniel [7 ]
White, Anne Marie [8 ]
Hessey, Eva [8 ]
机构
[1] Med Univ Vienna, Vienna, Austria
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] UCSD, La Jolla, CA USA
[4] Univ Klinikum Wurzburg, Wurzburg, Germany
[5] Univ Udine, I-33100 Udine, Italy
[6] Washington Sch Med, St Louis, MO USA
[7] Med Univ Vienna, Vienna, Austria
[8] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1191 / 1191
页数:1
相关论文
共 50 条
  • [21] Repeated treatment courses of rituximab in rheumatoid arthritis: Sustained efficacy in patients with an inadequate response to one or more TNF inhibitors
    Keystone, E.
    Fleischmann, R. M.
    Emery, P.
    Chubick, A.
    Dougadoss, M.
    Baldassare, A. R.
    Bathon, J. M.
    Hessey, E.
    Hagerty, D.
    Coopers, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 432 - 432
  • [22] Sustained improvement with repeated courses of rituximab in patients with rheumatoid arthritis and an inadequate response or intolerance to one or more TNF inhibitors
    Keystone, Edward C.
    Pope, Janet
    Fleischmann, Roy M.
    Emery, Paul
    Chubick, Andrew
    Dougados, Maxime R.
    Baldassare, Andrew R.
    Bathon, Joan M.
    Hessey, Eva
    Hagerty, David
    Cooper, Simon
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1195 - 1195
  • [23] SUSTAINED EFFICACY IS ACHIEVED WITH MULTIPLE COURSES OF RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO ONE OR MORE TNF INHIBITORS
    Keystone, Edward
    Fleischmann, Roy
    Emery, Paul
    Dougados, Maxime
    Williams, Sarah
    Reynard, Mark
    RHEUMATOLOGY, 2011, 50 : 121 - 122
  • [24] Repeat treatment with rituximab improves physical function and quality of life in patients with rheumatoid arthritis and an inadequate response to TNF inhibitors
    Tak, P. P.
    Maksymowych, W. P.
    Mease, P.
    Bombardieri, S.
    Lue, C.
    Isaacs, J. D.
    Schechtman, J.
    Gray, D.
    Cravets, M.
    Safa-Leathers, S.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1612 - 1612
  • [25] Efficacy of rituximab in active RA patients with an inadequate response to one or more TNF inhibitors.
    Kremer, J. M.
    Tony, H. P.
    Tak, P. P.
    Luggen, M.
    Mariette, X.
    Hessey, E.
    McCabe, D.
    Safa-Leathers, S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S247 - S248
  • [26] The Concordance of Assessments of the Clinical Disease Activity Index (CDAI) Performed by a Rheumatologist and Rheumatology Nurses Using an Electronic Version in Patients with Rheumatoid Arthritis (RA)
    Khraishi, Majed
    Aslanov, Rana
    Lin, Li
    White, Karen
    Donovan, Brenda
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 980 - 980
  • [27] Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index
    Aletaha, Daniel
    Martinez-Avila, Jose
    Kvien, Tore K.
    Smolen, Josef S.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (07) : 1190 - 1196
  • [28] Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission
    Aletaha, Daniel
    Wang, Xin
    Zhong, Sheng
    Florentinus, Stefan
    Monastiriakos, Kelly
    Smolen, Josef S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 643 - 644
  • [29] Using Patient Reported Outcome Measures to Classify Disease Activity States in Rheumatoid Arthritis: A Comparison of Patient-Derived Versions of Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI) and Disease Activity Score 28 (DAS28)
    Carruthers, Erin
    Osaimi, Noura A. L.
    Goldsmith, Charles H.
    Adam, Paul
    Lacaille, Diane
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S177 - S178
  • [30] Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission
    Aletaha, Daniel
    Wang, Xin
    Zhong, Sheng
    Florentinus, Stefan
    Monastiriakos, Kelly
    Smolen, Josef S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (02) : 276 - 284